MLN4924: Preliminary Phase I data

Preliminary data from an ongoing, dose-escalation Phase I trial in 15 patients with AML or high-grade MDS

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE